Search research articles
Contact Us
Filters
Showing results (1-10 of 86) with videos related to
Page
of 9
Sort By:
Seminars in Nuclear Medicine
|
February 4, 2014
Molecular imaging of urogenital diseases
Steve Y Cho, Zsolt Szabo
Clinical Nuclear Medicine
|
October 7, 2011
Congenital agenesis of right parotid gland confounds MIBG scan interpretation in craniocervical neuroblastoma
Don Udall, Steve Y Cho
Seminars in Musculoskeletal Radiology
|
April 10, 2014
The role of PET in the evaluation of musculoskeletal infections
Steven P Rowe, Steve Y Cho
Radiologic Clinics of North America
|
August 16, 2021
PET Imaging for Breast Cancer
Amy M Fowler, Steve Y Cho
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 20, 2009
New agents and techniques for imaging prostate cancer
Atif Zaheer, Steve Y Cho, Martin G Pomper
Current Radiology Reports
|
October 26, 2013
Translational Molecular Imaging of Prostate Cancer
Ana P Kiess, Steve Y Cho, Martin G Pomper
Nuclear Medicine and Molecular Imaging
|
February 3, 2018
Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?
Hyung-Jun Im, Tyler Bradshaw, Meiyappan Solaiyappan, et al.
EJNMMI Physics
|
September 19, 2017
Comparison of novel multi-level Otsu (MO-PET) and conventional PET segmentation methods for measuring FDG metabolic tumor volume in patients with soft tissue sarcoma
Inki Lee, Hyung-Jun Im, Meiyappan Solaiyappan, et al.
Cancer Research
|
June 3, 2004
Proteasome-mediated destruction of the cyclin a/cyclin-dependent kinase 2 complex suppresses tumor cell growth in vitro and in vivo
Wei Chen, Jeongwu Lee, Steve Y Cho, et al.
Seminars in Nuclear Medicine
|
October 16, 2020
FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls
Steve Y Cho, Daniel T Huff, Robert Jeraj, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 86) with videos related to
Sort By:
Page
of 9
Seminars in Nuclear Medicine
|
February 4, 2014
Molecular imaging of urogenital diseases
Steve Y Cho, Zsolt Szabo
Clinical Nuclear Medicine
|
October 7, 2011
Congenital agenesis of right parotid gland confounds MIBG scan interpretation in craniocervical neuroblastoma
Don Udall, Steve Y Cho
Seminars in Musculoskeletal Radiology
|
April 10, 2014
The role of PET in the evaluation of musculoskeletal infections
Steven P Rowe, Steve Y Cho
Radiologic Clinics of North America
|
August 16, 2021
PET Imaging for Breast Cancer
Amy M Fowler, Steve Y Cho
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 20, 2009
New agents and techniques for imaging prostate cancer
Atif Zaheer, Steve Y Cho, Martin G Pomper
Current Radiology Reports
|
October 26, 2013
Translational Molecular Imaging of Prostate Cancer
Ana P Kiess, Steve Y Cho, Martin G Pomper
Nuclear Medicine and Molecular Imaging
|
February 3, 2018
Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?
Hyung-Jun Im, Tyler Bradshaw, Meiyappan Solaiyappan, et al.
EJNMMI Physics
|
September 19, 2017
Comparison of novel multi-level Otsu (MO-PET) and conventional PET segmentation methods for measuring FDG metabolic tumor volume in patients with soft tissue sarcoma
Inki Lee, Hyung-Jun Im, Meiyappan Solaiyappan, et al.
Cancer Research
|
June 3, 2004
Proteasome-mediated destruction of the cyclin a/cyclin-dependent kinase 2 complex suppresses tumor cell growth in vitro and in vivo
Wei Chen, Jeongwu Lee, Steve Y Cho, et al.
Seminars in Nuclear Medicine
|
October 16, 2020
FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls
Steve Y Cho, Daniel T Huff, Robert Jeraj, et al.
Page
of 9